Voyager Therapeutics
VYGR
VYGR
115 hedge funds and large institutions have $117M invested in Voyager Therapeutics in 2025 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 33 increasing their positions, 42 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
40% less capital invested
Capital invested by funds: $196M → $117M (-$78.7M)
52% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 27
Holders
115
Holding in Top 10
–
Calls
$169K
Puts
$127K
Top Buyers
| 1 | +$2.24M | |
| 2 | +$1.07M | |
| 3 | +$697K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$529K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$391K |
Top Sellers
| 1 | -$1.87M | |
| 2 | -$1.65M | |
| 3 | -$811K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$700K |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$678K |
